Registration Statement

Compass Therapeutics, Inc. Filed 2022-12-02 Acc 0001171843-22-007790

Documents 1

2024-08-30 S-3 Registration Statement
2022-12-07 UPLOAD SEC-generated Letter
2022-12-02 S-3 Registration Statement
2022-11-29 8-K Executive or director change
2022-11-25 4 Chief Operating Officer sold 24,500 shares at an average $4.23 ($103,708)
2021-07-09 S-3 Registration Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading cmpx20221201_s3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…